false 0001549145 0001549145 2024-05-16 2024-05-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest event Reported): May 16, 2024

 

BLUE BIOFUELS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

  

000-54942

  

46-4944960

(State or other jurisdiction  

(Commission

   (I.R.S. Employer
of incorporation)   File Number)   Identification No.)

 

3710 Buckeye Street, Suite 120, Palm Beach Gardens, FL 33410

(Address of principal executive offices)

 

(888) 607-3555

(Registrant’s telephone number, including area code)

 

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See: General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of Each Exchange on which registered
Common   BIOF   OTCQB

 

 

 

 
 

 

Item 4.01 Changes in Registrant’s Certifying Accountant

 

(a) Dismissal of Independent Registered Public Accounting Firm

 

On May 3, 2024, the independent audit firm BF Borgers CPA PC (“BF Borgers”) utilized by the Company was denied the privilege of appearing or practicing before the Securities and Exchange Commission as an accountant.

 

The report of BF Borgers on the Company’s consolidated financial statements for the fiscal year ended December 31, 2023, did not contain an adverse opinion or a disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope or accounting principles other than an explanatory paragraph relating to the Company’s ability to continue as a going concern.

 

During the fiscal year ended December 31, 2023, and through May 3, 2024, there were no “disagreements” with BF Borgers on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements if not resolved to the satisfaction of BF Borgers would have caused BF Borgers to make reference thereto in its reports on the consolidated financial statement for such years. During the fiscal year ended December 31, 2023, and through May 3, 2024, there have been no “reportable events” (as defined in Item 304(a)(1)(iv) and Item 304(a)(1)(v) of Registration S-K), except for the identified material weaknesses in its internal control over financial reporting as disclosed in the Company’s Annual Report.

 

The Company is not required to provide BF Borgers with a copy of the disclosure made herein in response to Item 304(a) of Regulation S-K due to the fact that BF Borgers is not currently permitted to appear or practice before the Commission, as noted in Staff Statement on Issuer Disclosure and Reporting Obligations in Light of Rule 102(e) Order against BF Borgers CPA PC, which was disseminated by the SEC on May 3, 2024.

 

(b) Engagement of New Independent Registered Public Accounting Firm

 

On May 16, 2024, the Company engaged Assure CPA, LLC (“Assure”) to serve as the Company’s independent accountant and PCAOB certified audit firm for purposes of auditing the Company’s financial statements for the periods ending December 31, 2023, and December 31, 2024, and reviewing the Company’s financial statements for the period ending March 31, 2024, and subsequent periods. The Company had no contact with Assure during the previous two years for any purpose.

 

Item 9.01. Financial Statements and Exhibits.

 

None

 

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BLUE BIOFUELS, INC.
     
Date: May 17, 2024 By /s/: Anthony Santelli
    Anthony Santelli,
    Chief Financial Officer

 

3

 

v3.24.1.1.u2
Cover
May 16, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 16, 2024
Entity File Number 000-54942
Entity Registrant Name BLUE BIOFUELS, INC.
Entity Central Index Key 0001549145
Entity Tax Identification Number 46-4944960
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 3710 Buckeye Street
Entity Address, Address Line Two Suite 120
Entity Address, City or Town Palm Beach Gardens
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33410
City Area Code (888)
Local Phone Number 607-3555
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common
Trading Symbol BIOF
Blue Biofuels (QB) (USOTC:BIOF)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Blue Biofuels (QB) Charts.
Blue Biofuels (QB) (USOTC:BIOF)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Blue Biofuels (QB) Charts.